Mike Crapo bought Pharma Partners, LLC Company: Pharma Partners, LLC (Englewood, CO) Description: The LLC funds research and clinical trials on a new class of drugs, metalloporphyrins. The lead drugs are BMX-010 and BMX-001.
November 27, 2017 · STOCK Act disclosure
Senator Mike Crapo (Republican-ID) bought Pharma Partners, LLC Company: Pharma Partners, LLC (Englewood, CO) Description: The LLC funds research and clinical trials on a new class of drugs, metalloporphyrins. The lead drugs are BMX-010 and BMX-001., a other transaction, valued at $50,001 - $100,000. The trade took place on November 27, 2017 and was disclosed on December 6, 2017 (owner: JT). Members of Congress must report such transactions within 45 days under the STOCK Act.
Type
Buy
Amount
$50,001 - $100,000
Transaction date
November 27, 2017
Disclosed
December 6, 2017
MemberMike Crapo
ChamberSenate
Party / StateRepublican · ID
AssetPharma Partners, LLC Company: Pharma Partners, LLC (Englewood, CO) Description: The LLC funds research and clinical trials on a new class of drugs, metalloporphyrins. The lead drugs are BMX-010 and BMX-001.
Security typeOther
OwnerJT
Amount range$50,001 - $100,000
Transaction dateNovember 27, 2017
Filing dateDecember 6, 2017
AmendmentNo
Asset description
Pharma Partners, LLC Company: Pharma Partners, LLC (Englewood, CO) Description: The LLC funds research and clinical trials on a new class of drugs, metalloporphyrins. The lead drugs are BMX-010 and BMX-001.